Tue, Jul 22, 2014, 10:56 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Navidea Biopharmaceuticals, Inc Message Board

  • thom988 thom988 Apr 1, 2013 4:11 PM Flag

    Navidea Biopharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference

     

    DUBLIN, Ohio--(BUSINESS WIRE)--Apr. 1, 2013-- Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr. Mark Pykett, Navidea’s President and Chief Executive Officer, will participate at the Future Leaders in the Biotech Industry Conference on April 5, 2013 at the Millennium Broadway Hotel & Conference Center, New York, NY. Dr. Pykett will provide an update of the Company and its development programs at 9:30 AM EDT.

    Sentiment: Strong Buy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NAVB
1.40+0.01(+0.72%)Jul 22 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.